Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

Emerging methods in comparative effectiveness and safety: symposium overview and summary.

Lohr KN.

Med Care. 2007 Oct;45(10 Supl 2):S5-8.

PMID:
17909383
[PubMed - indexed for MEDLINE]
2.

Comparative effectiveness research methods: symposium overview and summary.

Lohr KN.

Med Care. 2010 Jun;48(6 Suppl):S3-6. doi: 10.1097/MLR.0b013e3181e10434.

PMID:
20473188
[PubMed - indexed for MEDLINE]
3.
4.

Utilizing Medicare claims data for realā€time drug safety evaluations:is it feasible?

Hartzema AG, Racoosin JA, MaCurdy TE, Gibbs JM, Kelman JA.

Pharmacoepidemiol Drug Saf. 2011 Jul;20(7):684-8.

PMID:
21847800
[PubMed - indexed for MEDLINE]
5.

Methodologic challenges to studying patient safety and comparative effectiveness.

Strom BL.

Med Care. 2007 Oct;45(10 Supl 2):S13-5.

PMID:
17909371
[PubMed - indexed for MEDLINE]
6.

Evaluating the patient safety indicators: how well do they perform on Veterans Health Administration data?

Rosen AK, Rivard P, Zhao S, Loveland S, Tsilimingras D, Christiansen CL, Elixhauser A, Romano PS.

Med Care. 2005 Sep;43(9):873-84.

PMID:
16116352
[PubMed - indexed for MEDLINE]
8.

Developments in post-marketing comparative effectiveness research.

Schneeweiss S.

Clin Pharmacol Ther. 2007 Aug;82(2):143-56. Epub 2007 Jun 6. Review.

PMID:
17554243
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

What can we really learn from observational studies?: the need for empirical assessment of methodology for active drug safety surveillance and comparative effectiveness research.

Madigan D, Ryan P.

Epidemiology. 2011 Sep;22(5):629-31. doi: 10.1097/EDE.0b013e318228ca1d. No abstract available.

PMID:
21811110
[PubMed - indexed for MEDLINE]
10.

Relevance of the Agency for Healthcare Research and Quality Patient Safety Indicators for children's hospitals.

Sedman A, Harris JM 2nd, Schulz K, Schwalenstocker E, Remus D, Scanlon M, Bahl V.

Pediatrics. 2005 Jan;115(1):135-45. Epub 2004 Dec 3.

PMID:
15579669
[PubMed - indexed for MEDLINE]
11.

Challenges in the design and analysis of sequentially monitored postmarket safety surveillance evaluations using electronic observational health care data.

Nelson JC, Cook AJ, Yu O, Dominguez C, Zhao S, Greene SK, Fireman BH, Jacobsen SJ, Weintraub ES, Jackson LA.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:62-71. doi: 10.1002/pds.2324.

PMID:
22262594
[PubMed - indexed for MEDLINE]
12.

Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system.

Rassen JA, Schneeweiss S.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:41-9. doi: 10.1002/pds.2328.

PMID:
22262592
[PubMed - indexed for MEDLINE]
13.

Design considerations in an active medical product safety monitoring system.

Gagne JJ, Fireman B, Ryan PB, Maclure M, Gerhard T, Toh S, Rassen JA, Nelson JC, Schneeweiss S.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:32-40. doi: 10.1002/pds.2316.

PMID:
22262591
[PubMed - indexed for MEDLINE]
14.

The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction.

Platt R, Carnahan RM, Brown JS, Chrischilles E, Curtis LH, Hennessy S, Nelson JC, Racoosin JA, Robb M, Schneeweiss S, Toh S, Weiner MG.

Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:1-8. doi: 10.1002/pds.2343.

PMID:
22262586
[PubMed - indexed for MEDLINE]
15.

A primer of drug safety surveillance: an industry perspective. Part III: Managing adverse-event data.

Allan MC.

J Pharm Technol. 1992 Nov-Dec;8(6):259-73. Review.

PMID:
10122649
[PubMed - indexed for MEDLINE]
16.

The measurement and monitoring of surgical adverse events.

Bruce J, Russell EM, Mollison J, Krukowski ZH.

Health Technol Assess. 2001;5(22):1-194. Review.

PMID:
11532239
[PubMed - indexed for MEDLINE]
Free Article
17.

Potential use of routine databases in health technology assessment.

Raftery J, Roderick P, Stevens A.

Health Technol Assess. 2005 May;9(20):1-92, iii-iv. Review.

PMID:
15899148
[PubMed - indexed for MEDLINE]
Free Article
18.

Signal detection methodologies to support effective safety management.

van Manen RP, Fram D, DuMouchel W.

Expert Opin Drug Saf. 2007 Jul;6(4):451-64. Review.

PMID:
17688389
[PubMed - indexed for MEDLINE]
19.

Active surveillance of postmarket medical product safety in the Federal Partners' Collaboration.

Robb MA, Racoosin JA, Worrall C, Chapman S, Coster T, Cunningham FE.

Med Care. 2012 Nov;50(11):948-53. doi: 10.1097/MLR.0b013e31826c874d.

PMID:
23047784
[PubMed - indexed for MEDLINE]
20.

Postmarketing evaluations help determine contraceptive safety, efficacy.

[No authors listed]

Netw Res Triangle Park N C. 1988 Winter;9(2):1-2, 7.

PMID:
12280950
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk